Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group. by Noseworthy, J, Vandervoort, M, Ebers, G

Plasma exchange for MS. by Noseworthy, J, Vandervoort, M, Ebers, G

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS by Noseworthy, J, Vandervoort, M, Ebers, G

PLASMA-EXCHANGE FOR MS by Noseworthy, J, Vandervoort, M, Ebers, G

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866)) by Noseworthy, J, Vandervoort, M, Ebers, G

EDSS RELIABILITY - REPLY by Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. by Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

MS REFERENDUM - REPLY by Noseworthy, J, Vandervoort, M, Hopkins, M, Ebers, G

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL by Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop. by Noseworthy, J, Vandervoort, M, Hopkins, M, Ebers, G

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article] by Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial by Nosworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. by Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION by Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, B, Bell, D

Seizures in multiple sclerosis: A multi-centre study by Mandalfino, P, Koopman, W, Vandervoort, M, O'Connor, P, Hader, W, Brunet, D, Murray, T, Ebers, G

ACTIVE RELAPSING AND PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS HAVE SIMILAR MAGNETIC-RESONANCE-IMAGING BEHAVIOR - IMPLICATIONS FOR CLINICAL-TRIAL DESIGN by Noseworthy, J, Karlik, S, Wiebe, S, Hopkins, M, Vandervoort, M, Hewitt, L, Rice, G, Ebers, G, Lee, D

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY by Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, B, Mclay, C, Bell, D

The prevalence of primary Sjogren's syndrome in a multiple sclerosis population. by Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, BG, McLay, C, Bell, D

Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. by Wiebe, S, Lee, D, Karlik, S, Hopkins, M, Vandervoort, M, Wong, C, Hewitt, L, Rice, G, Ebers, G, Noseworthy, J

An open-trial evaluation of mitoxantrone in the treatment of progressive MS. by Noseworthy, J, Hopkins, M, Vandervoort, M, Karlik, S, Lee, D, Penman, M, Rice, G, Grinwich, K, Cauvier, H, Harris, B